Pentair to Report Q2 Earnings: What to Expect From the Stock?
The Zacks Consensus Estimate for PNR's second-quarter sales is pegged at $1.11 billion, indicating 1.4% growth from the year-ago reported figure.The consensus estimate for earnings is pegged at $1.33 per share. The Zacks Consensus Estimate for PNR's earnings has been unchanged in the past 60 days. The estimate indicates year-over-year growth of 9%. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)
Image Source: Zacks Investment Research
Pentair's Solid Earnings Surprise History
PNR's earnings beat the Zacks Consensus Estimates in the trailing four quarters, the average surprise being 5.9%. This is depicted in the following chart.
Image Source: Zacks Investment Research
What the Zacks Model Unveils for PNR
Our model does not predict an earnings beat for Pentair this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. That is not the case here, as you can see below.You can uncover the best stocks before they are reported with our Earnings ESP Filter.Earnings ESP: Pentair has an Earnings ESP of +1.26%.Zacks Rank: PNR currently carries a Zacks Rank of 4 (Sell).
Factors Likely to Have Shaped Pentair's Q2 Performance
After witnessing lower volumes for five consecutive quarters, the pool segment saw a rebound in volumes in the second quarter of 2024 with 17.1% growth. However, volume growth has since decelerated to 4.1% in the third quarter and 2% in the fourth quarter of 2024. In the first quarter of 2025, it declined to 1.5%. The company expects the Pool segment's sales to increase 4-5% in 2025. However, considering that new pool builds in 2024 were at historical lows, and the company expects it to be relatively flat in 2025, this raises concerns about the achievability of these targets.We anticipate lower volume growth of 1.2% for the second quarter of 2025. Pricing is expected to have had a favorable impact of 1.4%. This is expected to have been offset by the unfavorable impacts of currency translation of 0.5%. Our model projects the Pool segment's sales to be $399 million, indicating a year-over-year rise of 2.1%.The Flow and Water Solutions segments continue to bear the impacts of a weak residential market due to high interest rates. However, a slight pickup in volumes is likely to have aided the segment in the to-be-reported quarter.We expect the Flow segment's sales to be $407 million, indicating an increase of 2.5% from the prior-year quarter's actual. Our model predicts a 2.2% year-over-year increase in volumes, while pricing is expected to have a positive impact of 1.2%. Currency impacts are projected at a negative 0.9%.Our model predicts the Water Solutions segment's net sales to decline 1.3% year over year to $306 million. Ongoing weakness in the residential vertical is expected to lead to a 1.8% dip in volumes, which will likely be offset by a 1.1% rise in pricing. The unfavorable impacts of currency translation of 0.6% are also expected to have lowered its sales.Pentair has been witnessing a tight supply of raw materials, along with rising logistics costs. Despite the weakness in the Water segment and cost headwinds, the company has delivered margin expansion across its segments, aided by pricing, cost savings and gains from its Transformation initiatives. We expect this to have continued in the second quarter as well.
PNR Stock's Price Performance
Pentair shares have gained 32.9% in the past year compared with the industry's 4.6% growth.
Image Source: Zacks Investment Research
Stocks That Warrant a Look
Here are some companies with the right combination of elements to post an earnings beat in their upcoming releases.Emerson Electric Co. EMR, expected to release earnings on Aug 6, currently has an Earnings ESP of +0.46% and a Zacks Rank of 3. You can see the complete list of today's Zacks #1 Rank stocks here.
The consensus estimate for Emerson Electric's earnings for the third quarter of fiscal 2025 is pegged at $1.51 per share, indicating year-over-year growth of 5.6%. EMR has a trailing four-quarter average surprise of 3.4%.Illinois Tool Works Inc. ITW, slated to release second-quarter 2025 results on July 30, has an Earnings ESP of +0.97% and a Zacks Rank of 3 at present.The Zacks Consensus Estimate for Illinois Tool Works' second-quarter 2025 earnings is pegged at $2.55 per share, suggesting a year-over-year rise of 0.4%. ITW has a trailing four-quarter average surprise of 3%.Crown Holdings, Inc. CCK is scheduled to release second-quarter 2025 results on July 21. It currently has an Earnings ESP of +0.27% and a Zacks Rank of 3.The Zacks Consensus Estimate for Crown Holdings' earnings is pegged at $1.86 per share, which indicates a year-over-year increase of 2.8%. CCK has a trailing four-quarter average surprise of 16.3%.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Illinois Tool Works Inc. (ITW) : Free Stock Analysis Report
Emerson Electric Co. (EMR) : Free Stock Analysis Report
Crown Holdings, Inc. (CCK) : Free Stock Analysis Report
Pentair plc (PNR) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Pfizer (PFE) Surpasses Q2 Earnings and Revenue Estimates
Pfizer (PFE) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.6 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +34.48%. A quarter ago, it was expected that this drugmaker would post earnings of $0.64 per share when it actually produced earnings of $0.92, delivering a surprise of +43.75%. Over the last four quarters, the company has surpassed consensus EPS estimates four times. Pfizer, which belongs to the Zacks Large Cap Pharmaceuticals industry, posted revenues of $14.65 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 6.35%. This compares to year-ago revenues of $13.28 billion. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Pfizer shares have lost about 11.3% since the beginning of the year versus the S&P 500's gain of 7.6%. What's Next for Pfizer? While Pfizer has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Pfizer was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.86 on $17.37 billion in revenues for the coming quarter and $3.07 on $63.4 billion in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Large Cap Pharmaceuticals is currently in the top 37% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. One other stock from the same industry, Eli Lilly (LLY), is yet to report results for the quarter ended June 2025. The results are expected to be released on August 7. This drugmaker is expected to post quarterly earnings of $5.61 per share in its upcoming report, which represents a year-over-year change of +43.1%. The consensus EPS estimate for the quarter has been revised 1.5% lower over the last 30 days to the current level. Eli Lilly's revenues are expected to be $14.75 billion, up 30.5% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Pfizer Inc. (PFE) : Free Stock Analysis Report Eli Lilly and Company (LLY) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
San Francisco Chronicle
an hour ago
- San Francisco Chronicle
Jacobs Solutions: Fiscal Q3 Earnings Snapshot
DALLAS (AP) — DALLAS (AP) — Jacobs Solutions Inc. (J) on Tuesday reported fiscal third-quarter profit of $179.6 million. On a per-share basis, the Dallas-based company said it had profit of $1.55. Earnings, adjusted for one-time gains and costs, came to $1.62 per share. The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of $1.56 per share. The construction and technical services company posted revenue of $3.03 billion in the period. _____
Washington Post
3 hours ago
- Washington Post
Embraer: Q2 Earnings Snapshot
SAO PAULO — SAO PAULO — Embraer SA (ERJ) on Tuesday reported second-quarter profit of $78.6 million. The Sao Paulo-based company said it had net income of 43 cents per share. Losses, adjusted for non-recurring gains, were 2 cents per share. The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 47 cents per share.
